Victory Capital Management
TSHA icon

Victory Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Victory Capital Management’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$875K Sell
195,745
-19
-0% -$88 ﹤0.01% 1891
2025
Q4 		$1.08M Buy
195,764
+170,164
+665% +$826K ﹤0.01% 1796
2025
Q3 		$83.7K Buy
25,600
+108
+0.4% +$306 ﹤0.01% 2311
2025
Q2 		$58.9K Buy
25,492
+6,475
+34% +$14.1K ﹤0.01% 2368
2025
Q1 		$26.4K Buy
19,017
+16
+0.1% +$27 ﹤0.01% 2414
2024
Q4 		$32.9K Sell
19,001
-1,006
-5% -$2.09K ﹤0.01% 2424
2024
Q3 		$40.2K Buy
20,007
+1,945
+11% +$4.27K ﹤0.01% 2405
2024
Q2 		$40.5K Buy
18,062
+1,144
+7% +$3.33K ﹤0.01% 2386
2024
Q1 		$48.6K Buy
16,918
+1,318
+8% +$2.75K ﹤0.01% 2381
2023
Q4 		$27.6K Buy
+15,600
New +$31.1K ﹤0.01% 2489

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM